Fatty Liver: all 1,462 studies
Page 10 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Quantitative US for Hepatic SteatosisCompletedNCT04180631Not applicable
- A Study to Assess the Efficacy and Safety of VK2809 for 52 Weeks in Subjects With Biopsy Proven NASHCompletedNCT04173065Phase 2
- Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORERCompletedNCT04165343
- Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT04161703Not applicable
- A Pilot Study to Explore the Role of Gut Flora in Fatty LiverWithdrawnNCT04160949
- Safety and Tolerability of Oral Proglumide for NASHCompletedNCT04152473Phase 1
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy SubjectsCompletedNCT04146805Phase 1
- Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedNCT04142749Phase 3
- A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese SubjectsCompletedNCT04142424Phase 1
- Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT04140123Phase 1/2
- Study in Chinese Healthy Adults to Evaluate the Safety, Tolerability and Pharmacokinetics on ZSP0678, and the Effect of Food on ZSP0678 PharmacokineticsCompletedNCT04137055Phase 1
- Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in HumansCompletedNCT04130321Not applicable
- The Role of Bariatric Surgeries in Management of Nonalcoholic Fatty Liver DiseaseStatus unknownNCT04127370Not applicable
- Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic SyndromeCompletedNCT04117802Not applicable
- Curcumin for Pediatric Nonalcoholic Fatty Liver DiseaseWithdrawnNCT04109742Phase 2
- NAFLD Study: US vs Liver BiopsyStatus unknownNCT04101162Not applicable
- Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease Based on Artificial Intelligence.Status unknownNCT04099147
- Biological Adaptations of Strength Training.CompletedNCT04098484Not applicable
- Prevalence of NAFLD and Correlation With Its Main Risk Factors Among EgyptianStatus unknownNCT04081571
- The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic SteatohepatitisCompletedNCT04080947Phase 1/2
- The Effect of Probiotics on the Clinical Outcomes and Gut Microenvironment in Patients With Fatty LiverStatus unknownNCT04074889Not applicable
- Characterization of the Microbiome in Peritoneum, Jejunum, Rectum and StoolCompletedNCT04067440
- Role of a Wheat Containing Diet on Non-alcoholic SteatohepatitisCompletedNCT04066400Not applicable
- PET-MR Study of Fatty LiverActive, not recruitingNCT04063826Not applicable
- Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASHStatus unknownNCT04060368Not applicable
- Macrophage-mediated Inflammation in White Adipose Tissue and Non-alcoholic Fatty Liver Disease.CompletedNCT04059068
- Nonalcoholic Fatty Liver Disease in Morbidly Obese PatientsStatus unknownNCT04059029
- Glycemic Index/Saturated Fatty Acid Diet and Hepatic FatCompletedNCT04054297Not applicable
- Berberine and Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT04049396Not applicable
- Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver PatientsCompletedNCT04046718Not applicable
- Glucagon Resistance in Patients With NAFLDCompletedNCT04042142Not applicable
- Long-term Follow Up of Patients in the Birmingham and Lambeth Liver Evaluation Strategies (BALLETS) StudyCompletedNCT04022681
- Innovative Liver Elasticity, Attenuation, and Dispersion Ultrasound StudyStatus unknownNCT04012242
- EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRIStatus unknownNCT04012021Not applicable
- Diabetes, Exercise and Liver Fat (DELIVER)CompletedNCT04004273Not applicable
- A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver DiseaseCompletedNCT03998514Phase 1
- Exercise Study in Subjects With NAFLDCompletedNCT03995056Not applicable
- Nonalcoholic Steatohepatitis in HIV Mono-infection: Exploring Non-invasive Methods for Diagnosis and the Therapeutic Role of Vitamin ECompletedNCT03988725Not applicable
- Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver DiseaseCompletedNCT03986684
- Super HEROES: Searching How the Extract Rebaudioside Occludes Excess SteatosisCompletedNCT03985020Not applicable
- Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light SpectroscopyCompletedNCT03978247Not applicable
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of EYP001a in Healthy Volunteers and Nonalcoholic Steatohepatitis PatientsCompletedNCT03976687Phase 1
- Lifestyle Interventions for the Treatment of Non-alcoholic Fatty Liver Disease in Overweight and Obese AdultsStatus unknownNCT03972631Not applicable
- Omega-3 Supplementation for LIver VolumE Reduction Study (OLIVER) StudyStatus unknownNCT03972319Early Phase 1
- A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASHStatus unknownNCT03970031Phase 3
- NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)Status unknownNCT03968354
- Safety and Tolerability of HepaStem in Patients With Cirrhotic and Pre-cirrhotic NASH PatientsCompletedNCT03963921Phase 1/2
- Safety and Tolerability of Yaq-001 in Patients With Non-Alcoholic SteatohepatitisWithdrawnNCT03962608Not applicable
- Glycemic Characterization and Pancreatic Imaging Correlates in Cystic FibrosisCompletedNCT03961516
- Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)TerminatedNCT03953456Phase 2
- A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLDCompletedNCT03950882Phase 1
- To Evaluate the Effect of Nesinaact on Non-alcoholic Steatohepatitis Through MRI and Liver Fibroscan in Patients With Type 2 DiabetesStatus unknownNCT03950505Phase 4
- Chia Supplementation and Non Alcoholic Fatty Liver DiseaseCompletedNCT03942822Not applicable
- Interval Training Versus Electro Acupuncture on Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT03936803Not applicable
- Integrated Approaches for Identifying Molecular Targets in Liver DiseaseCompletedNCT03915002
- Fatty Liver Imaging Project ( FLIP ) Patient Pilot StudyWithdrawnNCT03914482Not applicable
- 12-Month Once-a-week HIIT Improves Body Adiposity and Liver FatCompletedNCT03912272Not applicable
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesCompletedNCT03910361Phase 4
- Dietary Modulation of Intestinal Microbiota as Trigger of Liver Health: Role of Bile Acids - "A Diet for Liver Health"CompletedNCT03897218Not applicable
- An Open-Label Study to Assess the Hepatic Protection Effect of SNP-612, in Patients With NAFLDTerminatedNCT03868566Phase 2
- NAFLD Among Patients With Chronic Kidney Disease and the Effect of Kidney TransplantationTerminatedNCT03866421
- NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction ReversalWithdrawnNCT03864835Not applicable
- The Effect of Curcumin on Liver Fat Content in Obese SubjectsCompletedNCT03864783Not applicable
- Hepatic Histology and Metabolism Following Total Pancreatectomy and PancreaticoduodenectomyStatus unknownNCT03864744
- Feasibility of VIIT in Adults With NASHCompletedNCT03861819Not applicable
- The Liver in the World Trade Center Health Program General Responder Cohort and ControlsCompletedNCT03858920
- Nicotinamide in Non-Alcoholic Fatty Liver Disease PatientsCompletedNCT03850886Phase 2
- Effectiveness and Tolerability of Phentermine in Patients Under Bariatric SurgeryCompletedNCT03849729Phase 4
- A Pathophysiological Study of the Postprandial Human Liver (PLS)CompletedNCT03849235Not applicable
- Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).Status unknownNCT03848390Not applicable
- Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver DiseaseCompletedNCT03847116
- Fighting Fatty Liver in IndiaStatus unknownNCT03844165Not applicable
- Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of PrognosisStatus unknownNCT03842748
- Role of Obeticholic Acid in the Patients of NAFLD With Raised ALTCompletedNCT03836937Not applicable
- Postprandial Lipotoxicity and Nonalcoholic Fatty Liver DiseaseCompletedNCT03836443Not applicable
- NAFLD Among Patients With Type 2 Diabetes and CKDCompletedNCT03826381
- NASH and Coronary DiseaseStatus unknownNCT03819283Not applicable
- Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic SteatohepatitisStatus unknownNCT03803540Phase 1
- Efficacy of Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets on the Patients With Newly Diagnosed Type 2 Diabetes Mellitus Combined With Non-alcoholic Fatty Liver DiseaseCompletedNCT03796975Phase 4
- Effectiveness and Adherence of Modified Alternate-day Calorie Restriction (MACR) in Non-Alcoholic Fatty Liver DiseaseCompletedNCT03791203Not applicable
- Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or ObesityStatus unknownNCT03787108
- Time Restricted Feeding on Nonalcoholic Fatty Liver DiseaseCompletedNCT03786523Not applicable
- Ketogenic Diet in Non-alcoholic Fatty Liver DiseaseCompletedNCT03784716Not applicable
- A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female SubjectsCompletedNCT03783897Phase 1
- Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled TrialCompletedNCT03774511Not applicable
- Immunomediated Non-alcoholic SteaTohepatitis; Prevalence and Characterization. INSTInCT StudyStatus unknownNCT03760172
- Intragastric Balloon in Compensated NASH(Non Alcoholic Steato Hepatitis) CirrhoticsCompletedNCT03753438
- Mechanism of DCs Dysfunction in Chronic HBV InfectionStatus unknownNCT03753308
- Efficacy of Silymarin in Patients With Non-alcoholic Fatty Liver Disease - The SILIVER TrialStatus unknownNCT03749070Not applicable
- Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male SubjectsCompletedNCT03748628Phase 1
- Identification of Microbial Properties Predicting a Worsening Course of Fatty Liver DiseaseTerminatedNCT03748511
- Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver DiseaseCompletedNCT03738358Not applicable
- The Effects of Low Carbohydrate Diet on Liver Fat Content and Mitochondrial FluxesActive, not recruitingNCT03737071Not applicable
- The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Non-alcoholic Fatty Liver Disease: A Randomized, Controlled StudyStatus unknownNCT03734510Not applicable
- A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsCompletedNCT03726827
- Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLDStatus unknownNCT03725631Not applicable
- Dapagliflozin Efficacy and Action in NASHCompletedNCT03723252Phase 3
- Liver Health and Metabolic Function in People With ObesityCompletedNCT03701828Not applicable
- De Novo Lipogenesis in Severity of NAFLDCompletedNCT03683589
- Evaluation of the Pharmacokinetics of Tropifexor in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Healthy Control SubjectsCompletedNCT03681457Phase 1